U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919860) titled 'Observation Study on the Efficacy and Safety of Hepatic Artery Embolization Combined With Radiofrequency Ablation for Hepatic Hemangioma: The Impact of Different Treatment Intervals' on Nov. 01.

Brief Summary: The goal of this observational study is to learn about the efficacy-safety profiles of combined hepatic arterial embolization (TAE) and laparoscopic radiofrequency ablation (RFA) in patients with hepatic hemangioma who receive sequential TAE-RFA treatment. The main question it aims to answer is: Does the time interval between TAE and subsequent RFA influence therapeutic efficacy and safety in patients with hepatic hemangioma re...